novoprolabs retatrutide ly3437943 (LY3437943) Retatrutide (LY3437943): Mechanism, NEJM Data

Semaglutide is a GLP-1 medication that helps patients lose 1015% of total body weight

Covering GLP-1s is really something that needs to at least be talked about by employers because its so prevalent in the industry right now, said Julie Stich, vice president of content at the International Foundation of Employee Benefit Plans (IFEBP)

For clinical decision-making support, resources like Healthcare.pro can guide patients seeking professional advice

Whether you have been diagnosed or are looking to find a doctor, they are ready to help

Healthy people actually have lower GLP-1 in general, but they can make more whenever they need it

However, there are limitations inherent with this method as a surrogate to evaluating loss of muscle mass (few studies specifically measure muscle mass)